These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6410746)

  • 1. Treatment of cerebral arteriovenous malformations: combined neurosurgical and neuroradiologic approach.
    Cromwell LD; Harris AB
    AJNR Am J Neuroradiol; 1983; 4(3):366-8. PubMed ID: 6410746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experience with bucrylate (isobutyl-2-cyanoacrylate) embolization of cerebral arteriovenous malformations during surgery.
    Whittle IR; Johnston IH; Besser M; Lamond TS; de Silva M
    Surg Neurol; 1983 May; 19(5):442-9. PubMed ID: 6845158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of cerebral arteriovenous malformations: a combined neurosurgical and neuroradiological approach.
    Cromwell LD; Harris AB
    J Neurosurg; 1980 May; 52(5):705-8. PubMed ID: 7373399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histologic analysis of tissue response to bucrylate-pantopaque mixture.
    Cromwell LD; Freeny PC; Kerber CW; Kunz LL; Harris AB; Shaw CM
    AJR Am J Roentgenol; 1986 Sep; 147(3):627-31. PubMed ID: 3488665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Embolization of cerebral arteriovenous malformations with bucrylate. Experience in a first series of 29 patients.
    Berthelsen B; Löfgren J; Svendsen P
    Acta Radiol; 1990 Jan; 31(1):13-21. PubMed ID: 2340219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Embolization of cerebral arteriovenous malformations with bucrylate.
    Debrun G; Vinuela F; Fox A; Drake CG
    J Neurosurg; 1982 May; 56(5):615-27. PubMed ID: 7069472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved technique of bucrylate embolisation in brain arteriovenous malformation. The use of additional temporary balloon occlusion.
    ApSimon HT; Khangure MS
    Acta Radiol Suppl; 1986; 369():618-20. PubMed ID: 2980574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of intracerebral arteriovenous malformations with isobutyl 2-cyanoacrylate: initial clinical experience.
    Bank WO; Kerber CW; Cromwell LD
    Radiology; 1981 Jun; 139(3):609-16. PubMed ID: 6165036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Liquid embolization for arteriovenous malformation with temporary balloon occlusion of another feeders].
    Abe H; Koike T; Minakawa T; Tanaka R
    Rinsho Hoshasen; 1989 Jun; 34(6):739-42. PubMed ID: 2614983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of cyanoacrylate for therapeutic embolization: preliminary experience.
    Cromwell LD; Kerber CW
    AJR Am J Roentgenol; 1979 May; 132(5):799-801. PubMed ID: 107749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Embolization of brain arteriovenous malformations with the diluted Onyx technique: initial experience.
    Xu H; Wang L; Guan S; Li D; Quan T
    Neuroradiology; 2019 Apr; 61(4):471-478. PubMed ID: 30712140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravascular use of isobutyl 2-cyanoacrylate: Part 1 Treatment of intracranial arteriovenous malformations.
    Samson D; Ditmore QM; Beyer CW
    Neurosurgery; 1981 Jan; 8(1):43-51. PubMed ID: 7207772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive thrombosis of brain arteriovenous malformations after embolization with isobutyl 2-cyanoacrylate.
    Viñuela F; Fox AJ; Debrun G; Drake CG; Peerless SJ; Girvin JP
    AJNR Am J Neuroradiol; 1983; 4(6):1233-8. PubMed ID: 6419564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endovascular treatment with isobutyl cyano acrylate in patients with arteriovenous malformation of the brain. Indications, results and complications.
    Merland JJ; Rüfenacht D; Laurent A; Guimaraens L
    Acta Radiol Suppl; 1986; 369():621-2. PubMed ID: 2980575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of intraoperative embolization with surgical resection for treatment of giant cerebral arteriovenous malformation.
    Zhao J; Wang C; Wang S; Li J; Sui D; Zhao Y
    Chin Med J (Engl); 1999 Mar; 112(3):273-7. PubMed ID: 11593566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraoperative embolisation of cerebral arteriovenous malformations with isobutyl-2-cyanoacrylate (bucrylate).
    de Lange JJ; Baerts WD; Pearce C
    Acta Anaesthesiol Belg; 1982; 33(3):211-4. PubMed ID: 6815977
    [No Abstract]   [Full Text] [Related]  

  • 17. Symptomatic pulmonary complications from liquid acrylate embolization of brain arteriovenous malformations.
    Pelz DM; Lownie SP; Fox AJ; Hutton LC
    AJNR Am J Neuroradiol; 1995 Jan; 16(1):19-26. PubMed ID: 7900592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraoperative embolization of cerebral arteriovenous malformations in the awake patient.
    Girvin JP; Fox AJ; Vinuela F; Drake CG
    Clin Neurosurg; 1983; 31():188-247. PubMed ID: 6680081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endovascular treatment of arteriovenous malformation in a child.
    Seruga T
    Wien Klin Wochenschr; 2004; 116 Suppl 2():64-7. PubMed ID: 15506314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined therapy of cerebral arteriovenous malformations: histological differences between a non-adhesive liquid embolic agent and n-butyl 2-cyanoacrylate (NBCA).
    Duffner F; Ritz R; Bornemann A; Freudenstein D; Wiendl H; Siekmann R
    Clin Neuropathol; 2002; 21(1):13-7. PubMed ID: 11846039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.